Individuals at clinical high-risk (CHR) who progress to fully psychotic symptoms have been observed to show a steeper rate of cortical gray matter reduction compared with those without symptomatic progression and with healthy controls. Whether such changes reflect processes associated with the pathophysiology of schizophrenia or exposure to antipsychotic drugs is unknown
Although schizophrenia is characterized by gray matter (GM) abnormalities, particularly in the prefr...
The current study provides a complete MRI analysis of thickness throughout the cerebral cortical man...
Although the underlying neurobiology of emerging psy-chotic disorders is not well understood, there ...
Individuals at clinical high-risk (CHR) who progress to fully psychotic symptoms have been observed ...
Progressive grey matter loss has been demonstrated among clinical high-risk (CHR) individuals who co...
In a recent prospective longitudinal neuroimaging study, clinical high-risk (CHR) individuals who la...
Background Grey matter volume and cortical thickness represent two complementary aspects of brain s...
Background: Ultra-high risk (UHR) for psychosis has been associated with widespread structural brain...
Background: Several cross-sectional studies report brain structure differences between healthy volun...
In a recent prospective longitudinal neuroimaging study, clinical high-risk (CHR) individuals who la...
Background: A structural neuroanatomical change indicating a reduction in brain tissue is a notable ...
Context: Whether cortical thickness changes in schizophrenia over time are more pronounced relative ...
BACKGROUND: Structural differences between the brains of people with schizophrenia and control s...
The location, extent and progression of longitudinal morphometric changes after first-episode of psy...
Context: Progressive brain abnormalities in schizophrenia remain controversial. Evidence of interrel...
Although schizophrenia is characterized by gray matter (GM) abnormalities, particularly in the prefr...
The current study provides a complete MRI analysis of thickness throughout the cerebral cortical man...
Although the underlying neurobiology of emerging psy-chotic disorders is not well understood, there ...
Individuals at clinical high-risk (CHR) who progress to fully psychotic symptoms have been observed ...
Progressive grey matter loss has been demonstrated among clinical high-risk (CHR) individuals who co...
In a recent prospective longitudinal neuroimaging study, clinical high-risk (CHR) individuals who la...
Background Grey matter volume and cortical thickness represent two complementary aspects of brain s...
Background: Ultra-high risk (UHR) for psychosis has been associated with widespread structural brain...
Background: Several cross-sectional studies report brain structure differences between healthy volun...
In a recent prospective longitudinal neuroimaging study, clinical high-risk (CHR) individuals who la...
Background: A structural neuroanatomical change indicating a reduction in brain tissue is a notable ...
Context: Whether cortical thickness changes in schizophrenia over time are more pronounced relative ...
BACKGROUND: Structural differences between the brains of people with schizophrenia and control s...
The location, extent and progression of longitudinal morphometric changes after first-episode of psy...
Context: Progressive brain abnormalities in schizophrenia remain controversial. Evidence of interrel...
Although schizophrenia is characterized by gray matter (GM) abnormalities, particularly in the prefr...
The current study provides a complete MRI analysis of thickness throughout the cerebral cortical man...
Although the underlying neurobiology of emerging psy-chotic disorders is not well understood, there ...